{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:14:54Z","timestamp":1791112494846,"version":"4.1.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2010,1,28]],"date-time":"2010-01-28T00:00:00Z","timestamp":1264636800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s12035-009-8097-5","type":"journal-article","created":{"date-parts":[[2010,1,27]],"date-time":"2010-01-27T02:26:30Z","timestamp":1264559190000},"page":"248-255","source":"Crossref","is-referenced-by-count":44,"title":["Targeting Glial Cells to Elucidate the Pathogenesis of Huntington\u2019s Disease"],"prefix":"10.1007","volume":"41","author":[{"given":"Han-Yun","family":"Hsiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijuang","family":"Chern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,28]]},"reference":[{"key":"8097_CR1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1176\/appi.neuropsych.15.1.108","volume":"15","author":"TC Neylan","year":"2003","unstructured":"Neylan TC (2003) Neurodegenerative disorders: George Huntington\u2019s description of hereditary chorea. J Neuropsychiatry Clin Neurosci 15:108","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"8097_CR2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"8097_CR3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pharmthera.2005.04.008","volume":"108","author":"H Ryu","year":"2005","unstructured":"Ryu H, Rosas HD, Hersch SM, Ferrante RJ (2005) The therapeutic role of creatine in Huntington\u2019s disease. Pharmacol Ther 108:193\u2013207","journal-title":"Pharmacol Ther"},{"key":"8097_CR4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","volume":"20","author":"SH Li","year":"2004","unstructured":"Li SH, Li XJ (2004) Huntingtin-protein interactions and the pathogenesis of Huntington\u2019s disease. Trends Genet 20:146\u2013154","journal-title":"Trends Genet"},{"key":"8097_CR5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","volume":"19","author":"KL Sugars","year":"2003","unstructured":"Sugars KL, Rubinsztein DC (2003) Transcriptional abnormalities in Huntington disease. Trends Genet 19:233\u2013238","journal-title":"Trends Genet"},{"key":"8097_CR6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1083\/jcb.200709080","volume":"180","author":"J Wang","year":"2008","unstructured":"Wang J, Wang CE, Orr A, Tydlacka S, Li SH, Li XJ (2008) Impaired ubiquitin-proteasome system activity in the synapses of Huntington\u2019s disease mice. J Cell Biol 180:1177\u20131189","journal-title":"J Cell Biol"},{"key":"8097_CR7","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/hmg\/ddp230","volume":"18","author":"MC Chiang","year":"2009","unstructured":"Chiang MC, Chen HM, Lai HL, Chen HW, Chou SY, Chen CM, Tsai FJ, Chern Y (2009) The A2A adenosine receptor rescues the urea cycle deficiency of Huntington\u2019s disease by enhancing the activity of the ubiquitin-proteasome system. Hum Mol Genet 18:2929\u20132942","journal-title":"Hum Mol Genet"},{"key":"8097_CR8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/hmg\/ddl481","volume":"16","author":"MC Chiang","year":"2007","unstructured":"Chiang MC, Chen HM, Lee YH, Chang HH, Wu YC, Soong BW, Chen CM, Wu YR, Liu CS, Niu DM, Wu JY, Chen YT, Chern Y (2007) Dysregulation of C\/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington\u2019s disease. Hum Mol Genet 16:483\u2013498","journal-title":"Hum Mol Genet"},{"key":"8097_CR9","doi-asserted-by":"crossref","first-page":"14331","DOI":"10.1074\/jbc.M413279200","volume":"280","author":"MC Chiang","year":"2005","unstructured":"Chiang MC, Lee YC, Huang CL, Chern Y (2005) cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant Huntingtin with expanded polyglutamine residues. J Biol Chem 280:14331\u201314340","journal-title":"J Biol Chem"},{"key":"8097_CR10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","volume":"93","author":"SY Chou","year":"2005","unstructured":"Chou SY, Lee YC, Chen HM, Chiang MC, Lai HL, Chang HH, Wu YC, Sun CN, Chien CL, Lin YS, Wang SC, Tung YY, Chang C, Chern Y (2005) CGS21680 attenuates symptoms of Huntington\u2019s disease in a transgenic mouse model. J Neurochem 93:310\u2013320","journal-title":"J Neurochem"},{"key":"8097_CR11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0896-6273(95)90345-3","volume":"14","author":"AH Sharp","year":"1995","unstructured":"Sharp AH, Loev SJ, Schilling G, Li SH, Li XJ, Bao J, Wagster MV, Kotzuk JA, Steiner JP, Lo A et al (1995) Widespread expression of Huntington\u2019s disease gene (IT15) protein product. Neuron 14:1065\u20131074","journal-title":"Neuron"},{"key":"8097_CR12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME, Friedlander RM, Silani V, Hayden MR, Timmusk T, Sipione S, Cattaneo E (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease. Science 293:493\u2013498","journal-title":"Science"},{"key":"8097_CR13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, Cordelieres FP, De Mey J, MacDonald ME, Lessmann V, Humbert S, Saudou F (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127\u2013138","journal-title":"Cell"},{"key":"8097_CR14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archneur.62.1.46","volume":"62","author":"S Gunawardena","year":"2005","unstructured":"Gunawardena S, Goldstein LS (2005) Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways. Arch Neurol 62:46\u201351","journal-title":"Arch Neurol"},{"key":"8097_CR15","doi-asserted-by":"crossref","unstructured":"Mestre T, Ferreira J, Coelho MM, Rosa M, Sampaio C (2009) Therapeutic interventions for symptomatic treatment in Huntington\u2019s disease. Cochrane Database Syst Rev CD006456","DOI":"10.1002\/14651858.CD006456.pub2"},{"key":"8097_CR16","doi-asserted-by":"crossref","unstructured":"Mestre T, Ferreira J, Coelho MM, Rosa M, Sampaio C (2009) Therapeutic interventions for disease progression in Huntington\u2019s disease. Cochrane Database Syst Rev CD006455","DOI":"10.1002\/14651858.CD006455.pub2"},{"key":"8097_CR17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0166-2236(99)01415-0","volume":"22","author":"PH Reddy","year":"1999","unstructured":"Reddy PH, Williams M, Tagle DA (1999) Recent advances in understanding the pathogenesis of Huntington\u2019s disease. Trends Neurosci 22:248","journal-title":"Trends Neurosci"},{"key":"8097_CR18","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1091\/mbc.12.5.1393","volume":"12","author":"S Waelter","year":"2001","unstructured":"Waelter S, Boeddrich A, Lurz R, Scherzinger E, Lueder G, Lehrach H, Wanker EE (2001) Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol Biol Cell 12:1393\u20131407","journal-title":"Mol Biol Cell"},{"key":"8097_CR19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1083\/jcb.200710158","volume":"181","author":"CE Wang","year":"2008","unstructured":"Wang CE, Zhou H, McGuire JR, Cerullo V, Lee B, Li SH, Li XJ (2008) Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin. J Cell Biol 181:803\u2013816","journal-title":"J Cell Biol"},{"key":"8097_CR20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cell.2009.03.018","volume":"137","author":"H Jeong","year":"2009","unstructured":"Jeong H, Then F, Melia TJ Jr, Mazzulli JR, Cui L, Savas JN, Voisine C, Paganetti P, Tanese N, Hart AC, Yamamoto A, Krainc D (2009) Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell 137:60\u201372","journal-title":"Cell"},{"key":"8097_CR21","first-page":"321","volume":"277","author":"J Segovia","year":"2004","unstructured":"Segovia J, Perez-Severiano F (2004) Oxidative damage in Huntington\u2019s disease. Methods Mol Biol 277:321\u2013334","journal-title":"Methods Mol Biol"},{"key":"8097_CR22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0361-9230(00)00238-0","volume":"52","author":"AJ Morton","year":"2000","unstructured":"Morton AJ, Leavens W (2000) Mice transgenic for the human Huntington\u2019s disease mutation have reduced sensitivity to kainic acid toxicity. Brain Res Bull 52:51\u201359","journal-title":"Brain Res Bull"},{"key":"8097_CR23","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1096\/fj.00-0730fje","volume":"15","author":"K Varani","year":"2001","unstructured":"Varani K, Rigamonti D, Sipione S, Camurri A, Borea PA, Cattabeni F, Abbracchio MP, Cattaneo E (2001) Aberrant amplification of A(2A) receptor signaling in striatal cells expressing mutant huntingtin. Faseb J 15:1245\u20131247","journal-title":"Faseb J"},{"key":"8097_CR24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2007.02.034","volume":"417","author":"A Martire","year":"2007","unstructured":"Martire A, Calamandrei G, Felici F, Scattoni ML, Lastoria G, Domenici MR, Tebano MT, Popoli P (2007) Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington\u2019s disease versus wild-type mice. Neurosci Lett 417:78\u201383","journal-title":"Neurosci Lett"},{"key":"8097_CR25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.nbd.2009.08.003","volume":"36","author":"X Li","year":"2009","unstructured":"Li X, Sapp E, Chase K, Comer-Tierney LA, Masso N, Alexander J, Reeves P, Kegel KB, Valencia A, Esteves M, Aronin N, Difiglia M (2009) Disruption of Rab11 activity in a knock-in mouse model of Huntington\u2019s disease. Neurobiol Dis 36:374\u2013383","journal-title":"Neurobiol Dis"},{"key":"8097_CR26","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","volume":"95","author":"JH Cha","year":"1998","unstructured":"Cha JH, Kosinski CM, Kerner JA, Alsdorf SA, Mangiarini L, Davies SW, Penney JB, Bates GP, Young AB (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc Natl Acad Sci U S A 95:6480\u20136485","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8097_CR27","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","volume":"86","author":"GJ Klapstein","year":"2001","unstructured":"Klapstein GJ, Fisher RS, Zanjani H, Cepeda C, Jokel ES, Chesselet MF, Levine MS (2001) Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington\u2019s disease transgenic mice. J Neurophysiol 86:2667\u20132677","journal-title":"J Neurophysiol"},{"key":"8097_CR28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","volume":"81","author":"C Cepeda","year":"2007","unstructured":"Cepeda C, Wu N, Andre VM, Cummings DM, Levine MS (2007) The corticostriatal pathway in Huntington\u2019s disease. Prog Neurobiol 81:253\u2013271","journal-title":"Prog Neurobiol"},{"key":"8097_CR29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.nbd.2008.03.010","volume":"31","author":"H Zhang","year":"2008","unstructured":"Zhang H, Li Q, Graham RK, Slow E, Hayden MR, Bezprozvanny I (2008) Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington\u2019s disease. Neurobiol Dis 31:80\u201388","journal-title":"Neurobiol Dis"},{"key":"8097_CR30","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1523\/JNEUROSCI.0660-09.2009","volume":"29","author":"J Liu","year":"2009","unstructured":"Liu J, Tang TS, Tu H, Nelson O, Herndon E, Huynh DP, Pulst SM, Bezprozvanny I (2009) Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2. J Neurosci 29:9148\u20139162","journal-title":"J Neurosci"},{"key":"8097_CR31","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","volume":"171","author":"JY Shin","year":"2005","unstructured":"Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ (2005) Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 171:1001\u20131012","journal-title":"J Cell Biol"},{"key":"8097_CR32","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1523\/JNEUROSCI.0116-08.2008","volume":"28","author":"SY Chou","year":"2008","unstructured":"Chou SY, Weng JY, Lai HL, Liao F, Sun SH, Tu PH, Dickson DW, Chern Y (2008) Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5\/RANTES) by astrocytes. J Neurosci 28:3277\u20133290","journal-title":"J Neurosci"},{"key":"8097_CR33","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bjorkqvist","year":"2008","unstructured":"Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, Raibon E, Lee RV, Benn CL, Soulet D, Magnusson A, Woodman B, Landles C, Pouladi MA, Hayden MR, Khalili-Shirazi A, Lowdell MW, Brundin P, Bates GP, Leavitt BR, Moller T, Tabrizi SJ (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J Exp Med 205:1869\u20131877","journal-title":"J Exp Med"},{"key":"8097_CR34","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1999.7170","volume":"159","author":"SK Singhrao","year":"1999","unstructured":"Singhrao SK, Neal JW, Morgan BP, Gasque P (1999) Increased complement biosynthesis by microglia and complement activation on neurons in Huntington\u2019s disease. Exp Neurol 159:362\u2013376","journal-title":"Exp Neurol"},{"key":"8097_CR35","first-page":"689","volume":"26","author":"RA Roos","year":"1985","unstructured":"Roos RA, Bots GT, Hermans J (1985) Neuronal nuclear membrane indentation and astrocyte\/neuron ratio in Huntington\u2019s disease. A quantitative electron microscopic study. J Hirnforsch 26:689\u2013693","journal-title":"J Hirnforsch"},{"key":"8097_CR36","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/glia.20526","volume":"55","author":"DA Simmons","year":"2007","unstructured":"Simmons DA, Casale M, Alcon B, Pham N, Narayan N, Lynch G (2007) Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington\u2019s disease. Glia 55:1074\u20131084","journal-title":"Glia"},{"key":"8097_CR37","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","volume":"130","author":"YF Tai","year":"2007","unstructured":"Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, Piccini P (2007) Microglial activation in presymptomatic Huntington\u2019s disease gene carriers. Brain 130:1759\u20131766","journal-title":"Brain"},{"key":"8097_CR38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","volume":"10","author":"CH Lin","year":"2001","unstructured":"Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, Ren S, Li XJ, Albin RL, Detloff PJ (2001) Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease. Hum Mol Genet 10:137\u2013144","journal-title":"Hum Mol Genet"},{"key":"8097_CR39","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/cdd.2008.172","volume":"16","author":"JJ Rodriguez","year":"2009","unstructured":"Rodriguez JJ, Olabarria M, Chvatal A, Verkhratsky A (2009) Astroglia in dementia and Alzheimer\u2019s disease. Cell Death Differ 16:378\u2013385","journal-title":"Cell Death Differ"},{"key":"8097_CR40","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn1722","volume":"6","author":"A Volterra","year":"2005","unstructured":"Volterra A, Meldolesi J (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6:626","journal-title":"Nat Rev Neurosci"},{"key":"8097_CR41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncpneuro0355","volume":"2","author":"NJ Maragakis","year":"2006","unstructured":"Maragakis NJ, Rothstein JD (2006) Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2:679\u2013689","journal-title":"Nat Clin Pract Neurol"},{"key":"8097_CR42","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0166-2236(97)01139-9","volume":"20","author":"JL Ridet","year":"1997","unstructured":"Ridet JL, Malhotra SK, Privat A, Gage FH (1997) Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20:570\u2013577","journal-title":"Trends Neurosci"},{"key":"8097_CR43","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00019052-200108000-00009","volume":"14","author":"M Vila","year":"2001","unstructured":"Vila M, Jackson-Lewis V, Guegan C, Wu DC, Teismann P, Choi DK, Tieu K, Przedborski S (2001) The role of glial cells in Parkinson\u2019s disease. Curr Opin Neurol 14:483\u2013489","journal-title":"Curr Opin Neurol"},{"key":"8097_CR44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2003.12.007","volume":"15","author":"NJ Maragakis","year":"2004","unstructured":"Maragakis NJ, Rothstein JD (2004) Glutamate transporters: animal models to neurologic disease. Neurobiol Dis 15:461\u2013473","journal-title":"Neurobiol Dis"},{"key":"8097_CR45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.1086071","volume":"302","author":"AM Clement","year":"2003","unstructured":"Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, Rule M, McMahon AP, Doucette W, Siwek D, Ferrante RJ, Brown RH Jr, Julien JP, Goldstein LS, Cleveland DW (2003) Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302:113\u2013117","journal-title":"Science"},{"key":"8097_CR46","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1523\/JNEUROSCI.0081-05.2005","volume":"25","author":"MS Forman","year":"2005","unstructured":"Forman MS, Lal D, Zhang B, Dabir DV, Swanson E, Lee VM, Trojanowski JQ (2005) Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration. J Neurosci 25:3539\u20133550","journal-title":"J Neurosci"},{"key":"8097_CR47","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.410390519","volume":"39","author":"LA Bristol","year":"1996","unstructured":"Bristol LA, Rothstein JD (1996) Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann Neurol 39:676\u2013679","journal-title":"Ann Neurol"},{"key":"8097_CR48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.brainresrev.2004.05.003","volume":"47","author":"LH Barbeito","year":"2004","unstructured":"Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H, Viera L, Estevez AG, Beckman JS (2004) A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev 47:263\u2013274","journal-title":"Brain Res Brain Res Rev"},{"key":"8097_CR49","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","volume":"8","author":"JC Lievens","year":"2001","unstructured":"Lievens JC, Woodman B, Mahal A, Spasic-Boscovic O, Samuel D, Kerkerian-Le Goff L, Bates GP (2001) Impaired glutamate uptake in the R6 Huntington\u2019s disease transgenic mice. Neurobiol Dis 8:807\u2013821","journal-title":"Neurobiol Dis"},{"key":"8097_CR50","volume-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms","author":"J Bradford","year":"2010","unstructured":"Bradford J, Shin JY, Roberts M, Wang CE, Li X-J, Li S (2010) Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc Natl Acad Sci U S A, Epub Ahead of Print"},{"key":"8097_CR51","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbr.2009.03.022","volume":"202","author":"SC Fowler","year":"2009","unstructured":"Fowler SC, Miller BR, Gaither TW, Johnson MA, Rebec GV (2009) Force-plate quantification of progressive behavioral deficits in the R6\/2 mouse model of Huntington\u2019s disease. Behav Brain Res 202:130\u2013137","journal-title":"Behav Brain Res"},{"key":"8097_CR52","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/B:NERE.0000014822.69384.0f","volume":"29","author":"SJ Heales","year":"2004","unstructured":"Heales SJ, Lam AA, Duncan AJ, Land JM (2004) Neurodegeneration or neuroprotection: the pivotal role of astrocytes. Neurochem Res 29:513\u2013519","journal-title":"Neurochem Res"},{"key":"8097_CR53","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.mp.4001893","volume":"11","author":"PS Chen","year":"2006","unstructured":"Chen PS, Peng GS, Li G, Yang S, Wu X, Wang CC, Wilson B, Lu RB, Gean PW, Chuang DM, Hong JS (2006) Valproate protects dopaminergic neurons in midbrain neuron\/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry 11:1116\u20131125","journal-title":"Mol Psychiatry"},{"key":"8097_CR54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.nbd.2006.04.008","volume":"23","author":"A Saavedra","year":"2006","unstructured":"Saavedra A, Baltazar G, Santos P, Carvalho CM, Duarte EP (2006) Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: role of neuron-glia crosstalk. Neurobiol Dis 23:533\u2013542","journal-title":"Neurobiol Dis"},{"key":"8097_CR55","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","volume":"260","author":"LF Lin","year":"1993","unstructured":"Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130\u20131132","journal-title":"Science"},{"key":"8097_CR56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1471-4906(00)01812-3","volume":"22","author":"V Appay","year":"2001","unstructured":"Appay V, Rowland-Jones SL (2001) RANTES: a versatile and controversial chemokine. Trends in Immunology 22:83","journal-title":"Trends in Immunology"},{"key":"8097_CR57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-5728(97)00158-6","volume":"81","author":"LM Bolin","year":"1998","unstructured":"Bolin LM, Murray R, Lukacs NW, Strieter RM, Kunkel SL, Schall TJ, Bacon KB (1998) Primary sensory neurons migrate in response to the chemokine RANTES. J Neuroimmunol 81:49\u201357","journal-title":"J Neuroimmunol"},{"key":"8097_CR58","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/35055057","volume":"3","author":"M Bakhiet","year":"2001","unstructured":"Bakhiet M, Tjernlund A, Mousa A, Gad A, Stromblad S, Kuziel WA, Seiger A, Andersson J (2001) RANTES promotes growth and survival of human first-trimester forebrain astrocytes. Nat Cell Biol 3:150\u2013157","journal-title":"Nat Cell Biol"},{"key":"8097_CR59","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.0953-816X.2004.03374.x","volume":"19","author":"TL Spires","year":"2004","unstructured":"Spires TL, Grote HE, Garry S, Cordery PM, Van Dellen A, Blakemore C, Hannan AJ (2004) Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6\/1 Huntington\u2019s disease transgenic mice. Eur J NeuroSci 19:2799\u20132807","journal-title":"Eur J NeuroSci"},{"key":"8097_CR60","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1152\/jn.00791.2004","volume":"93","author":"MA Ariano","year":"2005","unstructured":"Ariano MA, Cepeda C, Calvert CR, Flores-Hernandez J, Hernandez-Echeagaray E, Klapstein GJ, Chandler SH, Aronin N, DiFiglia M, Levine MS (2005) Striatal potassium channel dysfunction in Huntington\u2019s disease transgenic mice. J Neurophysiol 93:2565\u20132574","journal-title":"J Neurophysiol"},{"key":"8097_CR61","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.tips.2008.08.004","volume":"29","author":"J El Khoury","year":"2008","unstructured":"El Khoury J, Luster AD (2008) Mechanisms of microglia accumulation in Alzheimer\u2019s disease: therapeutic implications. Trends Pharmacol Sci 29:626\u2013632","journal-title":"Trends Pharmacol Sci"},{"key":"8097_CR62","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/WCO.0b013e3280adc943","volume":"20","author":"A Klegeris","year":"2007","unstructured":"Klegeris A, McGeer EG, McGeer PL (2007) Therapeutic approaches to inflammation in neurodegenerative disease. Curr Opin Neurol 20:351\u2013357","journal-title":"Curr Opin Neurol"},{"key":"8097_CR63","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/glia.20210","volume":"51","author":"SA Sargsyan","year":"2005","unstructured":"Sargsyan SA, Monk PN, Shaw PJ (2005) Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 51:241\u2013253","journal-title":"Glia"},{"key":"8097_CR64","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1096\/fj.02-0429rev","volume":"17","author":"E Hansson","year":"2003","unstructured":"Hansson E, Ronnback L (2003) Glial neuronal signaling in the central nervous system. Faseb J 17:341\u2013348","journal-title":"Faseb J"},{"key":"8097_CR65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1139\/Y05-143","volume":"84","author":"AY Lai","year":"2006","unstructured":"Lai AY, Todd KG (2006) Microglia in cerebral ischemia: molecular actions and interactions. Can J Physiol Pharmacol 84:49\u201359","journal-title":"Can J Physiol Pharmacol"},{"key":"8097_CR66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0006-8993(96)00156-4","volume":"720","author":"M Ii","year":"1996","unstructured":"Ii M, Sunamoto M, Ohnishi K, Ichimori Y (1996) Beta-amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res 720:93\u2013100","journal-title":"Brain Res"},{"key":"8097_CR67","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.freeradbiomed.2008.05.026","volume":"45","author":"A Roy","year":"2008","unstructured":"Roy A, Jana A, Yatish K, Freidt MB, Fung YK, Martinson JA, Pahan K (2008) Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: implications for neurodegenerative diseases. Free Radic Biol Med 45:686\u2013699","journal-title":"Free Radic Biol Med"},{"key":"8097_CR68","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jneuroim.2008.08.006","volume":"205","author":"J Jiao","year":"2008","unstructured":"Jiao J, Xue B, Zhang L, Gong Y, Li K, Wang H, Jing L, Xie J, Wang X (2008) Triptolide inhibits amyloid-beta1-42-induced TNF-alpha and IL-1beta production in cultured rat microglia. J Neuroimmunol 205:32\u201336","journal-title":"J Neuroimmunol"},{"key":"8097_CR69","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/glia.20886","volume":"57","author":"I Szaingurten-Solodkin","year":"2009","unstructured":"Szaingurten-Solodkin I, Hadad N, Levy R (2009) Regulatory role of cytosolic phospholipase A2alpha in NADPH oxidase activity and in inducible nitric oxide synthase induction by aggregated Abeta1-42 in microglia. Glia 57:1727\u20131740","journal-title":"Glia"},{"key":"8097_CR70","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O\u2019Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer\u2019s disease. Neurobiol Aging 21:383\u2013421","journal-title":"Neurobiol Aging"},{"key":"8097_CR71","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/jlb.65.4.409","volume":"65","author":"PL McGeer","year":"1999","unstructured":"McGeer PL, McGeer EG (1999) Inflammation of the brain in Alzheimer\u2019s disease: implications for therapy. J Leukoc Biol 65:409\u2013415","journal-title":"J Leukoc Biol"},{"key":"8097_CR72","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1073\/pnas.162350199","volume":"99","author":"T Wyss-Coray","year":"2002","unstructured":"Wyss-Coray T, Yan F, Lin AH, Lambris JD, Alexander JJ, Quigg RJ, Masliah E (2002) Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer\u2019s mice. Proc Natl Acad Sci U S A 99:10837\u201310842","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8097_CR73","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1385\/JMN:21:1:65","volume":"21","author":"S Rotshenker","year":"2003","unstructured":"Rotshenker S (2003) Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3\/MAC-1)-mediated myelin phagocytosis in injury and disease. J Mol Neurosci 21:65\u201372","journal-title":"J Mol Neurosci"},{"key":"8097_CR74","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","volume":"193","author":"A Hald","year":"2005","unstructured":"Hald A, Lotharius J (2005) Oxidative stress and inflammation in Parkinson\u2019s disease: is there a causal link? Exp Neurol 193:279\u2013290","journal-title":"Exp Neurol"},{"key":"8097_CR75","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","volume":"100","author":"DC Wu","year":"2003","unstructured":"Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, Przedborski S (2003) NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 100:6145\u20136150","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8097_CR76","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.brainres.2006.09.100","volume":"1139","author":"S Jana","year":"2007","unstructured":"Jana S, Maiti AK, Bagh MB, Banerjee K, Das A, Roy A, Chakrabarti S (2007) Dopamine but not 3, 4-dihydroxy phenylacetic acid (DOPAC) inhibits brain respiratory chain activity by autoxidation and mitochondria catalyzed oxidation to quinone products: implications in Parkinson\u2019s disease. Brain Res 1139:195\u2013200","journal-title":"Brain Res"},{"key":"8097_CR77","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0197-0186(01)00124-3","volume":"40","author":"M Orth","year":"2002","unstructured":"Orth M, Schapira AH (2002) Mitochondrial involvement in Parkinson\u2019s disease. Neurochem Int 40:533\u2013541","journal-title":"Neurochem Int"},{"key":"8097_CR78","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K","volume":"47","author":"SJ Tabrizi","year":"2000","unstructured":"Tabrizi SJ, Workman J, Hart PE, Mangiarini L, Mahal A, Bates G, Cooper JM, Schapira AH (2000) Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 transgenic mouse. Ann Neurol 47:80\u201386","journal-title":"Ann Neurol"},{"key":"8097_CR79","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","volume":"66","author":"N Pavese","year":"2006","unstructured":"Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F, Barker RA, Brooks DJ, Piccini P (2006) Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66:1638\u20131643","journal-title":"Neurology"},{"key":"8097_CR80","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-6147(99)01308-5","volume":"20","author":"F Mennicken","year":"1999","unstructured":"Mennicken F, Maki R, de Souza EB, Quirion R (1999) Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol Sci 20:73\u201378","journal-title":"Trends Pharmacol Sci"},{"key":"8097_CR81","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrn752","volume":"3","author":"MD Nguyen","year":"2002","unstructured":"Nguyen MD, Julien JP, Rivest S (2002) Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 3:216\u2013227","journal-title":"Nat Rev Neurosci"},{"key":"8097_CR82","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0074-7742(07)82012-5","volume":"82","author":"J Rogers","year":"2007","unstructured":"Rogers J, Mastroeni D, Leonard B, Joyce J, Grover A (2007) Neuroinflammation in Alzheimer\u2019s disease and Parkinson\u2019s disease: are microglia pathogenic in either disorder? Int Rev Neurobiol 82:235\u2013246","journal-title":"Int Rev Neurobiol"},{"key":"8097_CR83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","volume":"52","author":"S Boillee","year":"2006","unstructured":"Boillee S, Vande Velde C, Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39\u201359","journal-title":"Neuron"},{"key":"8097_CR84","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","volume":"23","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG (2008) Glial reactions in Parkinson\u2019s disease. Mov Disord 23:474\u2013483","journal-title":"Mov Disord"},{"key":"8097_CR85","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","volume":"24","author":"M Sastre","year":"2006","unstructured":"Sastre M, Klockgether T, Heneka MT (2006) Contribution of inflammatory processes to Alzheimer\u2019s disease: molecular mechanisms. Int J Dev Neurosci 24:167\u2013176","journal-title":"Int J Dev Neurosci"},{"key":"8097_CR86","first-page":"245","volume":"18","author":"V Calabrese","year":"2004","unstructured":"Calabrese V, Boyd-Kimball D, Scapagnini G, Butterfield DA (2004) Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes. In Vivo 18:245\u2013267","journal-title":"In Vivo"},{"key":"8097_CR87","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jnr.1057","volume":"64","author":"AW Deckel","year":"2001","unstructured":"Deckel AW (2001) Nitric oxide and nitric oxide synthase in Huntington\u2019s disease. J Neurosci Res 64:99\u2013107","journal-title":"J Neurosci Res"},{"key":"8097_CR88","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.2741\/2259","volume":"12","author":"AM Blanco","year":"2007","unstructured":"Blanco AM, Guerri C (2007) Ethanol intake enhances inflammatory mediators in brain: role of glial cells and TLR4\/IL-1RI receptors. Front Biosci 12:2616\u20132630","journal-title":"Front Biosci"},{"key":"8097_CR89","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.brainresrev.2004.12.030","volume":"48","author":"B Marchetti","year":"2005","unstructured":"Marchetti B, Serra PA, Tirolo C, L\u2019Episcopo F, Caniglia S, Gennuso F, Testa N, Miele E, Desole S, Barden N, Morale MC (2005) Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions. Brain Res Brain Res Rev 48:302\u2013321","journal-title":"Brain Res Brain Res Rev"},{"key":"8097_CR90","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.molmed.2004.10.006","volume":"10","author":"MS Beattie","year":"2004","unstructured":"Beattie MS (2004) Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol Med 10:580\u2013583","journal-title":"Trends Mol Med"},{"key":"8097_CR91","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/brain\/awh452","volume":"128","author":"MT Heneka","year":"2005","unstructured":"Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C, O\u2019Banion K, Klockgether T, Van Leuven F, Landreth GE (2005) Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain 128:1442\u20131453","journal-title":"Brain"},{"key":"8097_CR92","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1523\/JNEUROSCI.22-06-02246.2002","volume":"22","author":"PT Jantzen","year":"2002","unstructured":"Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, Gordon MN (2002) Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J Neurosci 22:2246\u20132254","journal-title":"J Neurosci"},{"key":"8097_CR93","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3233\/JAD-2006-9S330","volume":"9","author":"PL McGeer","year":"2006","unstructured":"McGeer PL, Rogers J, McGeer EG (2006) Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12\u00a0years. J Alzheimers Dis 9:271\u2013276","journal-title":"J Alzheimers Dis"},{"key":"8097_CR94","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/glia.20338","volume":"53","author":"TJ Seabrook","year":"2006","unstructured":"Seabrook TJ, Jiang L, Maier M, Lemere CA (2006) Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice. Glia 53:776\u2013782","journal-title":"Glia"},{"key":"8097_CR95","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57\u201369","journal-title":"Nat Rev Neurosci"},{"key":"8097_CR96","first-page":"83","volume":"86","author":"PL McGeer","year":"2001","unstructured":"McGeer PL, Yasojima K, McGeer EG (2001) Inflammation in Parkinson\u2019s disease. Adv Neurol 86:83\u201389","journal-title":"Adv Neurol"},{"key":"8097_CR97","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","volume":"46","author":"JW Langston","year":"1999","unstructured":"Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine exposure. Ann Neurol 46:598\u2013605","journal-title":"Ann Neurol"},{"key":"8097_CR98","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","volume":"35","author":"T Wyss-Coray","year":"2002","unstructured":"Wyss-Coray T, Mucke L (2002) Inflammation in neurodegenerative disease\u2013a double-edged sword. Neuron 35:419\u2013432","journal-title":"Neuron"},{"key":"8097_CR99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.035048","volume":"304","author":"B Liu","year":"2003","unstructured":"Liu B, Hong JS (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304:1\u20137","journal-title":"J Pharmacol Exp Ther"},{"key":"8097_CR100","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2006.10.008","volume":"25","author":"MG Purisai","year":"2007","unstructured":"Purisai MG, McCormack AL, Cumine S, Li J, Isla MZ, Di Monte DA (2007) Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration. Neurobiol Dis 25:392\u2013400","journal-title":"Neurobiol Dis"},{"key":"8097_CR101","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.neuroscience.2007.02.055","volume":"147","author":"I Glezer","year":"2007","unstructured":"Glezer I, Simard AR, Rivest S (2007) Neuroprotective role of the innate immune system by microglia. Neuroscience 147:867\u2013883","journal-title":"Neuroscience"},{"key":"8097_CR102","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","volume":"49","author":"AR Simard","year":"2006","unstructured":"Simard AR, Soulet D, Gowing G, Julien JP, Rivest S (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer\u2019s disease. Neuron 49:489\u2013502","journal-title":"Neuron"},{"key":"8097_CR103","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1088469","volume":"302","author":"A Monsonego","year":"2003","unstructured":"Monsonego A, Weiner HL (2003) Immunotherapeutic approaches to Alzheimer\u2019s disease. Science 302:834\u2013838","journal-title":"Science"},{"key":"8097_CR104","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.1832501100","volume":"100","author":"X Wang","year":"2003","unstructured":"Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, Ferrante RJ, Kristal BS, Friedlander RM (2003) Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington\u2019s disease. Proc Natl Acad Sci U S A 100:10483\u201310487","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8097_CR105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbadis.2005.11.002","volume":"1762","author":"EC Stack","year":"2006","unstructured":"Stack EC, Smith KM, Ryu H, Cormier K, Chen M, Hagerty SW, Del Signore SJ, Cudkowicz ME, Friedlander RM, Ferrante RJ (2006) Combination therapy using minocycline and coenzyme Q10 in R6\/2 transgenic Huntington\u2019s disease mice. Biochim Biophys Acta 1762:373\u2013380","journal-title":"Biochim Biophys Acta"},{"key":"8097_CR106","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1385\/NMM:9:1:47","volume":"9","author":"S Mievis","year":"2007","unstructured":"Mievis S, Levivier M, Communi D, Vassart G, Brotchi J, Ledent C, Blum D (2007) Lack of minocycline efficiency in genetic models of Huntington\u2019s disease. Neuromolecular Med 9:47\u201354","journal-title":"Neuromolecular Med"},{"key":"8097_CR107","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"8097_CR108","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1074\/jbc.M708192200","volume":"283","author":"F Giorgini","year":"2008","unstructured":"Giorgini F, Moller T, Kwan W, Zwilling D, Wacker JL, Hong S, Tsai LC, Cheah CS, Schwarcz R, Guidetti P, Muchowski PJ (2008) Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment. J Biol Chem 283:7390\u20137400","journal-title":"J Biol Chem"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-009-8097-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-009-8097-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-009-8097-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:37:40Z","timestamp":1559443060000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-009-8097-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,28]]},"references-count":108,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["8097"],"URL":"https:\/\/doi.org\/10.1007\/s12035-009-8097-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,28]]}}}